VIKHEYLO Trademark

Trademark Overview

On Friday, April 3, 2026, a trademark application was filed for VIKHEYLO with the United States Patent and Trademark Office. The USPTO has given the VIKHEYLO trademark a serial number of 99742766. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, April 3, 2026. This trademark is owned by Intellia Therapeutics, Inc.. The VIKHEYLO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations; Pharmaceutical and biological preparations formulated for medical purposes to treat genetic protein disorders; Pharmaceutical and biological preparations for treating hereditary angioedema (HAE); Pharmaceutical and biological preparations for managing symptoms and complications from recurrent and localized tissue swelling occurring in hereditary angioedema (HAE); Pharmaceutical and biological preparations comprising CRISPR/Cas components for treating hereditary angioedema (HAE); Pharmaceutical and biological preparations comprising a Cas9 mRNA and a guide RNA for treating hereditary angioedema (HAE)
vikheylo

General Information

Serial Number99742766
Word MarkVIKHEYLO
Filing DateFriday, April 3, 2026
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, April 3, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesPharmaceutical and biological preparations; Pharmaceutical and biological preparations formulated for medical purposes to treat genetic protein disorders; Pharmaceutical and biological preparations for treating hereditary angioedema (HAE); Pharmaceutical and biological preparations for managing symptoms and complications from recurrent and localized tissue swelling occurring in hereditary angioedema (HAE); Pharmaceutical and biological preparations comprising CRISPR/Cas components for treating hereditary angioedema (HAE); Pharmaceutical and biological preparations comprising a Cas9 mRNA and a guide RNA for treating hereditary angioedema (HAE)
Description of MarkThe mark consists of the word VIKHEYLO with a lower right leg of the letter "K" extending below the lower left leg of the letter "H," with four arcs displayed to the left of the letter "V" and a pinwheel shape over the letter "V.".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 3, 2026
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIntellia Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
US

Trademark Events

Event DateEvent Description
Friday, April 3, 2026NEW APPLICATION ENTERED
Friday, April 3, 2026APPLICATION FILING RECEIPT MAILED

Related Keywords

vikheylo pharmaceutical preparations biological hereditary angioedema treating comprising guide tissue localized